APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acute Intermittent Porphyria Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Acute Intermittent Porphyria Drugs Industry Growth and Trends Forecast to 2032

22 December 202576 pages

Choose your research edition.

Industry ResearchAcute Intermittent Porphyria Drugs Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Acute Intermittent Porphyria Drugs Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Acute Intermittent Porphyria Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acute Intermittent Porphyria Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Acute Intermittent Porphyria Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Acute Intermittent Porphyria Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Acute Intermittent Porphyria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Acute Intermittent Porphyria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acute Intermittent Porphyria Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Acute Intermittent Porphyria Drugs include Recordati Rare Diseases. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Acute Intermittent Porphyria Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Acute Intermittent Porphyria Drugs market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acute Intermittent Porphyria Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acute Intermittent Porphyria Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Acute Intermittent Porphyria Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Acute Intermittent Porphyria Drugs Market by Company

Recordati Rare Diseases

Acute Intermittent Porphyria Drugs Segment by Type

313mg

350mg

Acute Intermittent Porphyria Drugs Segment by Application

Hospital

Pharmacy

Acute Intermittent Porphyria Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Intermittent Porphyria Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acute Intermittent Porphyria Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Intermittent Porphyria Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Acute Intermittent Porphyria Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Acute Intermittent Porphyria Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 313mg Table 2. Major Company of 350mg Table 3. Global Acute Intermittent Porphyria Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (units) Table 5. Global Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Acute Intermittent Porphyria Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Acute Intermittent Porphyria Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Acute Intermittent Porphyria Drugs Sales by Type (2027-2032) & (units) Table 10. Global Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Acute Intermittent Porphyria Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Acute Intermittent Porphyria Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Acute Intermittent Porphyria Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (units) Table 15. North America Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (units) Table 17. Europe Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (units) Table 21. Latin America Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Acute Intermittent Porphyria Drugs Industry Trends Table 25. Acute Intermittent Porphyria Drugs Industry Drivers Table 26. Acute Intermittent Porphyria Drugs Industry Opportunities and Challenges Table 27. Acute Intermittent Porphyria Drugs Industry Restraints Table 28. Global Acute Intermittent Porphyria Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Acute Intermittent Porphyria Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Acute Intermittent Porphyria Drugs Sales by Company (2021-2026) & (units) Table 31. Global Acute Intermittent Porphyria Drugs Sales Share by Company (2021-2026) Table 32. Global Acute Intermittent Porphyria Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Acute Intermittent Porphyria Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Acute Intermittent Porphyria Drugs Major Company Production Sites and Headquarters Table 35. Global Acute Intermittent Porphyria Drugs Company, Product Type & Application Table 36. Global Acute Intermittent Porphyria Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Acute Intermittent Porphyria Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Acute Intermittent Porphyria Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Acute Intermittent Porphyria Drugs Sales by Region (2021-2026) & (units) Table 41. Global Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Acute Intermittent Porphyria Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Acute Intermittent Porphyria Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Acute Intermittent Porphyria Drugs Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Acute Intermittent Porphyria Drugs Sales by Region (2027-2032) & (units) Table 46. Global Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Acute Intermittent Porphyria Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Acute Intermittent Porphyria Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Acute Intermittent Porphyria Drugs Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Acute Intermittent Porphyria Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (units) Table 52. Global Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Acute Intermittent Porphyria Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Acute Intermittent Porphyria Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Acute Intermittent Porphyria Drugs Sales by Application (2027-2032) & (units) Table 57. Global Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Acute Intermittent Porphyria Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Acute Intermittent Porphyria Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Acute Intermittent Porphyria Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (units) Table 62. North America Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (units) Table 64. Europe Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (units) Table 68. Latin America Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Recordati Rare Diseases Company Information Table 72. Recordati Rare Diseases Business Overview Table 73. Recordati Rare Diseases Acute Intermittent Porphyria Drugs Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Recordati Rare Diseases Acute Intermittent Porphyria Drugs Product Portfolio Table 75. Recordati Rare Diseases Recent Development Table 76. North America Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 77. North America Acute Intermittent Porphyria Drugs Sales by Country (2021-2026) & (units) Table 78. North America Acute Intermittent Porphyria Drugs Sales Market Share by Country (2021-2026) Table 79. North America Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032) & (units) Table 80. North America Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Country (2027-2032) Table 81. North America Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Acute Intermittent Porphyria Drugs Market Share by Country (2021-2026) Table 84. North America Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Acute Intermittent Porphyria Drugs Market Share Forecast by Country (2027-2032) Table 86. Europe Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 87. Europe Acute Intermittent Porphyria Drugs Sales by Country (2021-2026) & (units) Table 88. Europe Acute Intermittent Porphyria Drugs Sales Market Share by Country (2021-2026) Table 89. Europe Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032) & (units) Table 90. Europe Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Acute Intermittent Porphyria Drugs Market Share by Country (2021-2026) Table 94. Europe Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Acute Intermittent Porphyria Drugs Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Acute Intermittent Porphyria Drugs Sales by Country (2021-2026) & (units) Table 98. Asia-Pacific Acute Intermittent Porphyria Drugs Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032) & (units) Table 100. Asia-Pacific Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Acute Intermittent Porphyria Drugs Market Share by Country (2021-2026) Table 104. Asia-Pacific Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Acute Intermittent Porphyria Drugs Market Share Forecast by Country (2027-2032) Table 106. Latin America Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 107. Latin America Acute Intermittent Porphyria Drugs Sales by Country (2021-2026) & (units) Table 108. Latin America Acute Intermittent Porphyria Drugs Sales Market Share by Country (2021-2026) Table 109. Latin America Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032) & (units) Table 110. Latin America Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Acute Intermittent Porphyria Drugs Market Share by Country (2021-2026) Table 114. Latin America Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Acute Intermittent Porphyria Drugs Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Country (2021-2026) & (units) Table 118. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032) & (units) Table 120. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Acute Intermittent Porphyria Drugs Market Share by Country (2021-2026) Table 124. Middle East and Africa Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Acute Intermittent Porphyria Drugs Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Acute Intermittent Porphyria Drugs Distributors List Table 129. Acute Intermittent Porphyria Drugs Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Acute Intermittent Porphyria Drugs Image Figure 2. Global Acute Intermittent Porphyria Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acute Intermittent Porphyria Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Acute Intermittent Porphyria Drugs Sales (2021-2032) & (units) Figure 5. 313mg Image Figure 6. Global 313mg Sales YoY Growth (2021-2032) & (units) Figure 7. 350mg Image Figure 8. Global 350mg Sales YoY Growth (2021-2032) & (units) Figure 9. Global Acute Intermittent Porphyria Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Acute Intermittent Porphyria Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Acute Intermittent Porphyria Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Acute Intermittent Porphyria Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Acute Intermittent Porphyria Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Acute Intermittent Porphyria Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Acute Intermittent Porphyria Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (units) Figure 27. Global Acute Intermittent Porphyria Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Acute Intermittent Porphyria Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Application in 2025 Figure 30. North America Acute Intermittent Porphyria Drugs Sales Market Share in Value by Application in 2025 Figure 31. Europe Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Application in 2025 Figure 32. Europe Acute Intermittent Porphyria Drugs Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Acute Intermittent Porphyria Drugs Sales Market Share in Value by Application in 2025 Figure 35. Latin America Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Acute Intermittent Porphyria Drugs Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Market Share in Value by Application in 2025 Figure 39. North America Acute Intermittent Porphyria Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 40. North America Acute Intermittent Porphyria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Acute Intermittent Porphyria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Acute Intermittent Porphyria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Acute Intermittent Porphyria Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. Europe Acute Intermittent Porphyria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Acute Intermittent Porphyria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Acute Intermittent Porphyria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Acute Intermittent Porphyria Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Asia-Pacific Acute Intermittent Porphyria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Acute Intermittent Porphyria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Acute Intermittent Porphyria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Acute Intermittent Porphyria Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Latin America Acute Intermittent Porphyria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Acute Intermittent Porphyria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Acute Intermittent Porphyria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Middle East and Africa Acute Intermittent Porphyria Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Acute Intermittent Porphyria Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Acute Intermittent Porphyria Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Acute Intermittent Porphyria Drugs Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Acute Intermittent Porphyria Drugs Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 313mg
  • 350mg
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Recordati Rare Diseases

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acute Intermittent Porphyria Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Acute Intermittent Porphyria Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Acute Intermittent Porphyria Drugs Market by Type
  6. 1.3.1 313mg
  7. 1.3.2 350mg
  8. 1.4 Global Acute Intermittent Porphyria Drugs Market Size by Type
  9. 1.4.1 Global Acute Intermittent Porphyria Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Acute Intermittent Porphyria Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Acute Intermittent Porphyria Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Acute Intermittent Porphyria Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Acute Intermittent Porphyria Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Acute Intermittent Porphyria Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Acute Intermittent Porphyria Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Acute Intermittent Porphyria Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Acute Intermittent Porphyria Drugs Industry Trends
  2. 2.2 Acute Intermittent Porphyria Drugs Industry Drivers
  3. 2.3 Acute Intermittent Porphyria Drugs Industry Opportunities and Challenges
  4. 2.4 Acute Intermittent Porphyria Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Acute Intermittent Porphyria Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Acute Intermittent Porphyria Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Acute Intermittent Porphyria Drugs Price (2021-2026)
  4. 3.4 Global Acute Intermittent Porphyria Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Acute Intermittent Porphyria Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Acute Intermittent Porphyria Drugs Company, Product Type & Application
  7. 3.7 Global Acute Intermittent Porphyria Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Acute Intermittent Porphyria Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Acute Intermittent Porphyria Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Acute Intermittent Porphyria Drugs Tier 1, Tier 2, and Tier 3
4 Acute Intermittent Porphyria Drugs Regional Status and Outlook
  1. 4.1 Global Acute Intermittent Porphyria Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Acute Intermittent Porphyria Drugs Historic Market Size by Region
  3. 4.2.1 Global Acute Intermittent Porphyria Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Acute Intermittent Porphyria Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Acute Intermittent Porphyria Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Acute Intermittent Porphyria Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Acute Intermittent Porphyria Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Acute Intermittent Porphyria Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Acute Intermittent Porphyria Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Acute Intermittent Porphyria Drugs by Application
  1. 5.1 Acute Intermittent Porphyria Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Acute Intermittent Porphyria Drugs Market Size by Application
  5. 5.2.1 Global Acute Intermittent Porphyria Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Acute Intermittent Porphyria Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Acute Intermittent Porphyria Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Acute Intermittent Porphyria Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Acute Intermittent Porphyria Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Acute Intermittent Porphyria Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Acute Intermittent Porphyria Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Acute Intermittent Porphyria Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Recordati Rare Diseases
  2. 6.1.1 Recordati Rare Diseases Company Information
  3. 6.1.2 Recordati Rare Diseases Business Overview
  4. 6.1.3 Recordati Rare Diseases Acute Intermittent Porphyria Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Recordati Rare Diseases Acute Intermittent Porphyria Drugs Product Portfolio
  6. 6.1.5 Recordati Rare Diseases Recent Developments
7 North America by Country
  1. 7.1 North America Acute Intermittent Porphyria Drugs Sales by Country
  2. 7.1.1 North America Acute Intermittent Porphyria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Acute Intermittent Porphyria Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Acute Intermittent Porphyria Drugs Market Size by Country
  6. 7.2.1 North America Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Acute Intermittent Porphyria Drugs Sales by Country
  2. 8.1.1 Europe Acute Intermittent Porphyria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Acute Intermittent Porphyria Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Acute Intermittent Porphyria Drugs Market Size by Country
  6. 8.2.1 Europe Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Acute Intermittent Porphyria Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Acute Intermittent Porphyria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Acute Intermittent Porphyria Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Acute Intermittent Porphyria Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Acute Intermittent Porphyria Drugs Sales by Country
  2. 10.1.1 South America Acute Intermittent Porphyria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Acute Intermittent Porphyria Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Acute Intermittent Porphyria Drugs Market Size by Country
  6. 10.2.1 South America Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Acute Intermittent Porphyria Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Acute Intermittent Porphyria Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Acute Intermittent Porphyria Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Acute Intermittent Porphyria Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Acute Intermittent Porphyria Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Acute Intermittent Porphyria Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Acute Intermittent Porphyria Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Acute Intermittent Porphyria Drugs Value Chain Analysis
  2. 12.1.1 Acute Intermittent Porphyria Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Acute Intermittent Porphyria Drugs Production Mode & Process
  7. 12.2 Acute Intermittent Porphyria Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Acute Intermittent Porphyria Drugs Distributors
  10. 12.2.3 Acute Intermittent Porphyria Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst